Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Franzini, Anca
Durr, Oliver
Baty, Florent
Brutsche, Martin
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Epithelial cell; Genetics; Cell biology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P821
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial)
    Franzini, Anca
    Baty, Florent
    Macovei, Ina I.
    Duerr, Oliver
    Droege, Cornelia
    Betticher, Daniel
    Grigoriu, Bogdan D.
    Klingbiel, Dirk
    Zappa, Francesco
    Brutsche, Martin H.
    CLINICAL CANCER RESEARCH, 2015, 21 (23) : 5253 - 5263
  • [2] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
    Poma, Anello Marcello
    Bruno, Rossella
    Pietrini, Iacopo
    Ali, Greta
    Pasquini, Giulia
    Proietti, Agnese
    Vasile, Enrico
    Cappelli, Sabrina
    Chella, Antonio
    Fontanini, Gabriella
    CANCERS, 2021, 13 (15)
  • [4] 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC)
    Baty, Florent
    Fruh, Martin
    Jorger, Markus
    Brutsche, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [5] Gene expression signatures in non-small cell lung cancer (NSCLC) according to cigarette smoking history
    Jassem, J.
    Szymanowska, A.
    Skrzypski, M.
    Costa, R. Rosell
    Taron, M.
    Chaib, I.
    Rzyman, W.
    Jarzab, M.
    Muley, T.
    Jassem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [7] Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer
    Ma, Ke
    Li, Yan-Xin
    Guo, Qian-Qian
    NEOPLASMA, 2022, 69 (05) : 1092 - 1100
  • [8] Identification of Metabolic Signatures Associated with Erlotinib Resistance of Non-small Cell Lung Cancer Cells
    Serizawa, Masakuni
    Kusuhara, Masatoshi
    Zangiacomi, Vincent
    Urakami, Kenichi
    Watanabe, Masaru
    Takahashi, Toshiaki
    Yamaguchi, Ken
    Yamamoto, Nobuyuki
    Koh, Yasuhiro
    ANTICANCER RESEARCH, 2014, 34 (06) : 2779 - 2787
  • [9] PROGRESS WITH CANDIDATE PREDICTIVE GENE EXPRESSION SIGNATURES FOR MEK INHIBITORS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Brant, Roz
    Liptrot, Tom
    Rooney, Claire
    Brown, Helen
    Mcewen, Robert
    Mcwalter, Gael
    Dougherty, Brian
    Walker, Jill
    Orr, Maria C.
    Harrington, Liz
    Barrett, Carl
    Dry, Jonathan
    Smith, Paul
    Hodgson, Darren
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1096 - S1096
  • [10] Detection of Gene Expression Signatures in Tumor Free Lymph Node Tissue Predicts Prognosis in Non-Small Cell Lung Cancer (NSCLC)
    Anderlind, C.
    Brothers, J. F., II
    Daly, B. D. T.
    Lenburg, M.
    Brody, J. S.
    Hinds, A.
    Ebright, M. I.
    Fernando, H. C.
    Reardon, C.
    O'Hara, C. J.
    Spira, A.
    Kathuria, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345